The Technical Analyst
COMPASS Pathways Plc - [CMPS]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Care Facilities
COMPASS Pathways Plc - Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: BUY (auto-tracking)
-0.48% $8.38
America/New_York / 19 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 519.09 mill |
| EPS: | -2.32 |
| P/E: | -3.61 |
| Earnings Date: | May 06, 2024 |
| SharesOutstanding: | 61.94 mill |
| Avg Daily Volume: | 0.714 mill |
| RATING 2024-04-19 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Buy | |
| P/E: | Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -3.61 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.13x |
| Company: PE -3.61 | industry: PE 28.38 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$3.68 (-56.13%) $-4.70 |
| Date: 2024-04-20 |
| Expected Trading Range (DAY) |
|---|
|
$ 7.58 - 9.18 ( +/- 9.59%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-16 | Goldsmith George Jay | Sell | 23 881 | Ordinary Shares |
| 2024-04-16 | Goldsmith George Jay | Sell | 23 880 | Ordinary Shares |
| 2024-04-17 | Goldsmith George Jay | Sell | 10 850 | Ordinary Shares |
| 2024-04-17 | Goldsmith George Jay | Sell | 10 850 | Ordinary Shares |
| 2024-04-16 | Malievskaia Ekaterina | Sell | 23 881 | Ordinary Shares |
| INSIDER POWER |
|---|
| -21.90 |
| Last 98 transactions |
| Buy: 820 261 | Sell: 1 253 383 |
Forecast:
16:00 - $8.38
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $8.38
Forecast 2: 16:00 - $8.38
Forecast 3: 16:00 - $8.38
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $8.38 (-0.48% ) |
| Volume | 0.368 mill |
| Avg. Vol. | 0.714 mill |
| % of Avg. Vol | 51.51 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For CMPS
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $10.99 | N/A | Active |
|---|
CMPS
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
Last 10 Buy Signals
Latest Press Releases
2024-04-01 16:01:00 - Press Release
Compass Pathways To Participate In Upcoming 23rd Annual Needham Virtual Healthcare Conference
London, april 01, 2024 (globe newswire) -- compass pathways plc (nasdaq: cmps), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the 23rd annual needham virtual healthcare conference at 8:00am et on april 9, 2024.
2024-03-28 08:00:00 - Press Release
Compass Pathways Board Chair And Co-founder George Goldsmith And Co-founder Ekaterina Malievskaia Step Down From Board Of Directors
David norton assumes role of interim board chair while the company runs a global search for a new chair david norton assumes role of interim board chair while the company runs a global search for a new chair
2024-02-29 07:00:00 - Press Release
Compass Pathways Announces Fourth Quarter 2023 Financial Results And Business Highlights
London, feb. 29, 2024 (globe newswire) -- compass pathways plc (nasdaq: cmps) (“compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the fourth quarter 2023 and provided an update on recent progress across its business.
2024-02-26 16:01:00 - Press Release
Compass Pathways To Participate In Upcoming Td Cowen Investor Conference
London, feb. 26, 2024 (globe newswire) -- compass pathways plc (nasdaq: cmps), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in a panel discussion at the td cowen 44th annual health care conference at 12:50 pm et on march 4, 2024.
2024-02-22 16:01:00 - Press Release
Compass Pathways To Announce Fourth Quarter And Year-end 2023 Financial Results On February 29, 2024
London, feb. 22, 2024 (globe newswire) -- compass pathways plc (nasdaq: cmps), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the fourth quarter and year-end 2023 ending december 31, 2023, and provide an update on recent business developments, on february 29, 2024.
Latest News
2024-03-05 09:30:00 - The Motley Fool
3 Biopharma Stocks You Don't Want to Miss in the New Bull Market
Vertex Pharmaceuticals is angling to treat acute pain with its new drug. Compass Pathways will have a major data update sometime in Q4.
2024-02-27 12:33:48 - InvestorPlace
Penny Power Players: 3 Stocks to Watch in the Microcap Arena
There are some great microcap stocks for investors to scoop up this month. The broader indices, such as the S&P 500 and the Nasdaq, are showing signs of both strength and weakness, but I believe that there's still a lot of gas left in the tank for these to surge higher.
2024-02-26 16:01:00 - GlobeNewsWire
Compass Pathways to participate in upcoming TD Cowen investor conference
LONDON, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in a panel discussion at the TD Cowen 44th Annual Health Care Conference at 12:50 pm ET on March 4, 2024.
2024-02-19 07:00:00 - The Motley Fool
Wall Street Says Compass Pathways Could Rise 307%. Here's How It Could Actually Happen.
Compass will report some critical clinical trial data this year. One of its peers could soon see its first drug approved.
2024-01-31 16:01:00 - GlobeNewsWire
Compass Pathways to participate in upcoming Oppenheimer investor conference
LONDON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fireside chat at the Oppenheimer 34th Annual Healthcare Life Sciences Conference at 2:00 pm ET on February 13, 2024.
2024-01-09 13:56:16 - InvestorPlace
Therapy's New Frontier: 3 Psychedelic Stocks for the Mental Health Revolution
Though psychedelic therapies and related psychedelic stocks have fallen out of favor recently, there's still tremendous research and insight happening beneath the surface. Even Elon Musk uses ketamine as a depression therapeutic.
2024-01-09 12:00:00 - Seeking Alpha
De-Risking Psychedelics: Compass Pathways, Cybin And Atai
Critical catalysts are approaching in the psychedelic sector, with the potential for the first FDA-approved psychedelic therapy by the end of the year.
2024-01-08 11:47:01 - The Motley Fool
3 Big New Catalysts for Psychedelics Stocks in 2024
Psychedelics stocks could be buoyed by a few positive events soon. The government is now funding the study of certain psychedelics.
2023-12-05 16:09:31 - InvestorPlace
Investing in Mental Health: 3 Stocks in the Wellness Space
Mental health stocks are democratizing access to mental health services for millions across the globe. The lack of access to qualified counselors is a significant hurdle for people to get the help they need (primarily due to financial commitments).
2023-11-24 08:00:00 - GlobeNewsWire
Compass Pathways to participate in upcoming Evercore investor conference
LONDON, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference at 10:25 am ET on November 30, 2023.